ENTERRA
Report
- Report Number
- 3004209178-2018-15595
- Event Type
- Malfunction
- Date Received
- July 12, 2018
- Date of Event
- June 11, 2018
- Report Date
- October 5, 2018
- Manufacturer
- MEDTRONIC PUERTO RICO OPERATIONS CO.
- Product Code
- LNQ
- UDI-DI
- 00643169614246
- PMA / PMN Number
- H990014
- Adverse Event
- Yes
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- PA, US
- Reporter Occupation
- PHYSICIAN
Narratives
PRODUCT ID 4351-35 LOT# (B)(4).(B)(6)2018 EXPLANTED: PRODUCT TYPE LEAD MEDTRONIC, INC. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.
CONCOMITANT MEDICAL PRODUCTS: PRODUCT ID: 4351-35, SERIAL#: (B)(4), IMPLANTED: (B)(6) 2018, PRODUCT TYPE: LEAD. PRODUCT ID: 4351-35, SERIAL#: (B)(4), IMPLANTED: (B)(6) 2018, PRODUCT TYPE: LEAD. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.
IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.
ADDITIONAL INFORMATION WAS RECEIVED FROM A HCP VIA A REP. IT WAS REPORTED THAT THE REP AND HCP SAW THE PATIENT ON (B)(6)2018 AND THE PATIENT TOLD THEM THEY WERE FEELING GREAT AND THEIR DEVICE WAS HELPING THEM GAIN WEIGHT. THEY BELIEVED THE SHOCKING ONLY OCCURRED DURING THEIR MENSTRUAL CYCLE.
INFORMATION WAS RECEIVED FROM A HEALTHCARE PROFESSIONAL (HCP) VIA A MANUFACTURER REPRESENTATIVE (REP) REGARDING A PATIENT WHO WAS IMPLANTED WITH A NEUROSTIMULATOR FOR GASTRIC STIMULATION. IT WAS REPORTED THAT THE PATIENT WAS EXPERIENCING INTENSE SHOCKING FROM THEIR STIMULATOR SINCE THEIR SURGERY ON (B)(6) 2018. THE INTENSITY AND DURATION HAD INCREASED, ACCORDING TO THE PATIENT, AND A FOLLOW-UP APPOINTMENT WAS SCHEDULED FOR (B)(6) 2018 WITH THEIR HCP. NO FURTHER COMPLICATIONS WERE REPORTED OR ANTICIPATED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 525854 | ENTERRA | INTESTINAL STIMULATOR | LNQ | MEDTRONIC PUERTO RICO OPERATIONS CO. | 37800 | 00643169614246 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 25 YR |